These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 27896442

  • 21. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study.
    Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P.
    Intensive Care Med; 2004 Feb; 30(2):260-265. PubMed ID: 14600809
    [Abstract] [Full Text] [Related]

  • 22. The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study.
    Fisher R, Lei K, Mitchell MJ, Moore GW, Dickie H, Tovey L, Crichton S, Ostermann M.
    BMC Nephrol; 2017 Oct 02; 18(1):304. PubMed ID: 28969597
    [Abstract] [Full Text] [Related]

  • 23. Safety and Efficacy of Citrate Anticoagulation for Continuous Renal Replacement Therapy for Acute Kidney Injury After Liver Transplantation: A Single-Center Experience.
    Pertica N, Cicciarella L, Carraro A, Montin U, Violi P, Lupo A, Zaza G.
    Transplant Proc; 2017 May 02; 49(4):674-676. PubMed ID: 28457369
    [Abstract] [Full Text] [Related]

  • 24. Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study.
    Gould DW, Doidge J, Sadique MZ, Borthwick M, Hatch R, Caskey FJ, Forni L, Lawrence RF, MacEwen C, Ostermann M, Mouncey PR, Harrison DA, Rowan KM, Young JD, Watkinson PJ.
    Health Technol Assess; 2022 Feb 02; 26(13):1-58. PubMed ID: 35212260
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.
    Stucker F, Ponte B, Tataw J, Martin PY, Wozniak H, Pugin J, Saudan P.
    Crit Care; 2015 Mar 18; 19(1):91. PubMed ID: 25881975
    [Abstract] [Full Text] [Related]

  • 28. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V, Garg U, Warady BA, Alon US.
    Pediatr Nephrol; 2002 Oct 18; 17(10):819-24. PubMed ID: 12376810
    [Abstract] [Full Text] [Related]

  • 29. Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy.
    Zhu D, He J, Xiao Z, Zhou X, Zhang X.
    Sci Rep; 2024 Jun 12; 14(1):13504. PubMed ID: 38866989
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Citrate anticoagulation for continuous venovenous hemofiltration.
    Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF.
    Crit Care Med; 2009 Feb 12; 37(2):545-52. PubMed ID: 19114912
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study.
    Valle EO, Cabrera CPS, Albuquerque CCC, Silva GVD, Oliveira MFA, Sales GTM, Smolentzov I, Reichert BV, Andrade L, Seabra VF, Lins PRG, Rodrigues CE.
    Crit Care; 2021 Aug 19; 25(1):299. PubMed ID: 34412667
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Choice and management of anticoagulation during CRRT].
    Ricci D, Panicali L, Cavallari G, Facchini MG, Mancini E.
    G Ital Nefrol; 2019 Apr 19; 36(2):. PubMed ID: 30983172
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.